What We Learn from the CTAD (Clinical Trials Alzheimer's Disease) 2018
J Prev Alzheimers Dis
.
2018;5(4):214-215.
doi: 10.14283/jpad.2017.38.
Authors
B Vellas
1
,
P Aisen
,
M Weiner
,
J Touchon
Affiliation
1
Bruno Vellas, University of Toulouse, INSERM 1027, Gérontopôle, Toulouse, France, vellas.b@chu-toulouse.fr.
PMID:
30298178
DOI:
10.14283/jpad.2017.38
No abstract available
Publication types
Introductory Journal Article
MeSH terms
Alzheimer Disease / therapy*
Animals
Biomedical Research
Clinical Trials as Topic
Humans